Regulation of Nephron Progenitor Cell Self-Renewal and Differentiation
Regulation of Nephron Progenitor Cell Self-Renewal and Differentiation
批准号:
8638282
负责人:
MICHAEL I RAUCHMAN
金额:
$32.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-07 至 2018-04-30
关键词:
AgonistBindingBinding SitesBiochemicalCell Differentiation processCellsChIP-seqChildhoodChromatin Remodeling FactorChronic Kidney FailureComplementComplexCongenital AbnormalityDeacetylaseDevelopmentDifferentiation InhibitorElementsEmbryoEnd stage renal failureEndowmentEnhancersEnsureEpigenetic ProcessEpithelialEpithelial CellsEquilibriumGene ExpressionGene Expression RegulationGene TargetingGenesGeneticGenetically Engineered MouseGenomicsGoalsHumanHuman GeneticsHypertensionIn VitroInjuryKidneyKidney DiseasesKidney FailureKnock-in MouseKnowledgeLifeMaintenanceMapsMesenchymeMessenger RNAModelingMolecularMusMutant Strains MiceMutateNatural regenerationNephronsNucleosomesOrganOrgan Culture TechniquesOutputPatientsPlayPopulationRegulationRenal functionResearchRiskSignal TransductionSorting - Cell MovementStem cellsSyndromeTestingTherapeuticTranscriptional RegulationTubular formationUndifferentiatedUreterVesicleWorkepithelial to mesenchymal transitionexhaustiongenome wide association studyin vivoinhibitor/antagonistinsightmutantnephrogenesisnovelprecursor cellprematurepreventprogenitorpublic health relevancerepairedresearch studyresponseself-renewalstemnesstranscription factor
中文摘要
总结/摘要
这项工作的长期目标是确定Sall 1转录因子及其受体是如何被激活的。
相关的染色质重塑复合物控制基因调控,以产生正常的
肾单位这将阐明机制,人类遗传综合征和常见的零星出生
缺陷,如肾发育不全(肾小,肾单位数量减少),导致肾
失败
形成适当的肾单位的补充需要多能细胞扩张之间的平衡。
肾祖细胞和分化。Sall 1基因缺陷改变发育中的基因表达
肾,加速肾单位分化,导致肾单位祖细胞和肾
发育不全这些未定型的肾单位前体,称为帽间充质,必须响应典型的
Wnt/β-catenin信号通过自我更新或间充质-上皮转化形成大多数细胞,
肾单位的管状部分。控制这些相反的反应的转录机制,
帽间充质是未知的,但目前的证据表明,Sall 1是关键的发展,
决定
我们最近的研究为一种新的范式提供了证据。我们建议Sall 1与
核小体重塑和脱乙酰酶(NuRD)染色质重塑复合物,以确定肾单位
通过调节响应Wnt/β-连环蛋白的转录输出来调节祖细胞命运。
该应用程序将使用遗传、基因组和
生物化学方法。Six 2是肾单位分化的抑制剂。在目标1中,我们将确定Sall 1是否
直接上调帽间充质中Six 2的表达以抑制祖细胞的分化。
在Sall 1突变体中,主要分化信号Wnt 9 b的表达增加。我们将确定
增加的Wnt 9 b和减少的Six 2表达的组合足以引起加速的肾单位
自我更新祖细胞的形成和耗竭。目标2将确定Sall 1和NuRD如何控制
肾单位祖细胞中的转录输出,以确定未定型的前体细胞是否
进行自我更新或启动肾单位分化。从这些研究中获得的机械见解将
进一步努力在体外增殖肾单位祖细胞和/或促进成熟肾小管的再生
上皮细胞,以纠正肾单位缺陷。
英文摘要
SUMMARY/ABSTRACT
The long-term goal of the proposed work is to determine how the Sall1 transcription factor and its
associated chromatin remodeling complexes control gene regulation to generate a normal endowment of
nephrons. This will illuminate mechanisms that underlie human genetic syndromes and common sporadic birth
defects, such as renal hypoplasia (small kidneys with reduced numbers of nephrons), which result in kidney
failure.
Formation of the proper complement of nephrons requires a balance between expansion of multi-potent
renal progenitor cells and differentiation. Genetic deficiency of Sall1 alters gene expression in the developing
kidney, accelerating nephron differentiation leading to a depletion of nephron progenitor cells and renal
hypoplasia. These uncommitted nephron precursors, termed cap mesenchyme, must respond to canonical
Wnt/ss-catenin signals by either undergoing self-renewal or mesenchymal-to-epithelial transition to form most
tubular segments of the nephron. The transcriptional mechanisms that control these opposing responses of the
cap mesenchyme are not known, but current evidence argues that Sall1 is pivotal in this critical developmental
decision.
Our recent studies provide evidence for a novel paradigm. We propose that Sall1 cooperates with the
Nucleosome Remodeling and Deacetylase (NuRD) chromatin remodeling complex, to determine nephron
progenitor cell fate by regulating the transcriptional output in response to Wnt/ss-catenin.
This application will test key predictions of this model using a combination of genetic, genomic, and
biochemical approaches. Six2 is an inhibitor of nephron differentiation. In Aim 1, we will determine if Sall1
directly up-regulates Six2 expression in cap mesenchyme to restrain differentiation of progenitor cells.
Expression of Wnt9b, the main differentiation signal, is increased in Sall1 mutants. We will determine if the
combination of increased Wnt9b and reduced Six2 expression are sufficient to cause accelerated nephron
formation, and exhaustion of self-renewing progenitor cells. Aim 2 will determine how Sall1 and NuRD control
the transcriptional output in nephron progenitor cells to determine whether the uncommitted precursor cells
undergo self-renewal or initiate nephron differentiation. The mechanistic insights gained from these studies will
advance efforts to propagate nephron progenitors in vitro and/or promote regeneration of mature tubular
epithelial cells in order to correct nephron deficits.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research Project 2: Molecular analysis of developing post-natal mouse kidney in health and FSGS
-
批准号:10530271
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2022
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Research Project 2: Molecular analysis of developing post-natal mouse kidney in health and FSGS
-
批准号:10707966
-
项目类别:
-
资助金额:$19.3万
-
财政年份:2022
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Single Cell Chromatin Profiling in Kidney Tissue
-
批准号:10373426
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2021
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Epigenetic mechanisms of gene regulation in nephron progenitor cell proliferation and differentiation
-
批准号:10289761
-
项目类别:
-
资助金额:$42.22万
-
财政年份:2021
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Epigenetic mechanisms of gene regulation in nephron progenitor cell proliferation and differentiation
-
批准号:10672271
-
项目类别:
-
资助金额:$42.03万
-
财政年份:2021
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Epigenetic mechanisms of gene regulation in nephron progenitor cell proliferation and differentiation
-
批准号:10442628
-
项目类别:
-
资助金额:$42.22万
-
财政年份:2021
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Regulation of Nephron Progenitor Cell Self-Renewal and Differentiation
-
批准号:9607382
-
项目类别:
-
资助金额:$20.12万
-
财政年份:2018
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Mechanisms and Treatment of Kidney Fibrosis
-
批准号:10660981
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Regulation of Nephron Progenitor Cell Self-Renewal and Differentiation
-
批准号:9258431
-
项目类别:
-
资助金额:$12.83万
-
财政年份:2014
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Regulation of Nephron Progenitor Cell Self-Renewal and Differentiation
-
批准号:8908006
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2014
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Sall1 in Kidney Development and Townes-Brocks Syndrome
-
批准号:6761360
-
项目类别:
-
资助金额:$18.12万
-
财政年份:2004
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Sall1 in Kidney Development and Townes-Brocks Syndrome
-
批准号:6882644
-
项目类别:
-
资助金额:$18.12万
-
财政年份:2004
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Biochemical and Functional Studies of Sall1 in Kidney Development and TBS
-
批准号:7741059
-
项目类别:
-
资助金额:$33.26万
-
财政年份:2004
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Sall1 in Kidney Development and Townes-Brocks Syndrome
-
批准号:7054138
-
项目类别:
-
资助金额:$17.69万
-
财政年份:2004
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Sall1 in Kidney Development and Townes-Brocks Syndrome
-
批准号:7218716
-
项目类别:
-
资助金额:$17.18万
-
财政年份:2004
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
Biochemical and Functional Studies of Sall1 in Kidney Development and TBS
-
批准号:7939666
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2004
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
RENAL SODIUM-INOSITOL COTRANSPORT
-
批准号:2135448
-
项目类别:
-
资助金额:$3.53万
-
财政年份:1992
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
RENAL SODIUM-INOSITOL COTRANSPORT
-
批准号:3037285
-
项目类别:
-
资助金额:$3.53万
-
财政年份:1991
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
RENAL SODIUM-INOSITOL COTRANSPORT
-
批准号:3037284
-
项目类别:
-
资助金额:$3.3万
-
财政年份:1991
-
负责人:MICHAEL I RAUCHMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: